A sip of your morning coffee might do more than just waking you up

Kyle Gerick Tamayo

     Beyond flavor and aroma, the coffee that kickstarts your day might just have a roasted chemistry that carries tiny molecular allies in the ongoing struggle to fight diabetes.

     Researchers led by Minghua Qiu at the Kunming Institute of Botany, Chinese Academy of Sciences have found previously unknown compounds in roasted Coffea arabica beans that, in lab tests, blocked a key digestive enzyme linked to type 2 diabetes more strongly than a common anti-diabetic drug.

     In their detailed analysis, researchers identified three new compounds, namely Caffaldehydes A, B, and C— which are natural compounds that are formed during the high-temperature roasting process of the said coffee beans that has the capability of strongly inhibiting α-glucosidase — the enzyme responsible for breaking down carbohydrates into glucose.

     Alpha-glucosidase (α-glucosidase) is an enzyme in the small intestine that helps turn complex carbohydrates such as starches into simple sugars that enter the bloodstream after meals, and slowing its activity is a strategy used in diabetes management to reduce post-meal blood sugar spikes.

     When tested in laboratory assessment, all three caffaldehydes demonstrated stronger inhibition of α-glucosidase compared with acarbose, a standard drug used clinically to help control blood sugar in people with type 2 diabetes.

     Beyond isolating the main active compounds, the researchers also looked for other similar, hard-to-find molecules that might be present in very small amounts, helping them uncover even more potentially useful components in coffee.

     Coffee’s ability to inhibit carbohydrate-digesting enzymes has been hinted before: other studies show coffee extracts can reduce enzyme activity that breaks down starch and sugars, supporting the idea that coffee contains multiple compounds with potential effects on glucose metabolism.

     In the Philippines, diabetes remains a growing health problem, as the International Diabetes Federation (IDF) recorded approximately 7.5% or an estimated 4.7 million Filipinos aged 20-79 years old living with the disease.

     While the research does not mean that drinking coffee alone will treat or prevent type 2 diabetes, it expands the understanding of coffee’s hidden chemistry and highlights how specific components within common foods could one day play a role in metabolic health.

     Returning to that morning cup, the roasted chemistry of coffee with its tiny molecular allies now being unearthed may point toward food-based ways to better moderate blood sugar and could one day join the fight against diabetes.